The Victorian government has announced backing for pharmaceutical manufacturer IDT Australia to boost production of live-saving cancer treatments. IDT Australia will build a new facility in Boronia, Melbourne to manufacture Antibody Drug Conjugates (ADCs) which have the specificity of monoclonal antibodies and deliver chemotherapy agents to cancer tumor sites. ADCs are set to replace almost…
By Peter Roberts Companies have begun to receive belated notices from the federal government that their applications for grant support under the Morrison government’s Modern Manufacturing Initiative, with IDT Australia one that has opted for a full strategic review following news its bid for a MMI grant had failed. Industry minister Ed Husic this week…
While Canberra has announced an ‘in-principal’ agreement with US company Moderna to manufacture mRNA vaccines in Victoria, Melbourne pharmaceutical and vaccine manufacturer IDT Australia has announced it has been informed that it has missed out on government support. The company said today it was disappointed that its proposal to establish mRNA manufacturing in response to…
Pharmaceutical manufacturer and clinical trials group IDT Australia (ASX: IDT) is confident of better times ahead following a flat 2019 which saw revenue down on the previous year. The company, which manufactures pharmaceutical active ingredient and consumer dosage products, as well as conducting clinical trials, has recovered from an adverse situation with the US FDA…
Listed pharmaceutical company IDT Australia (ASX:IDT) has gained a Medical Cannabis Manufacturing Licence from the Office of Drug Control.
By Brian Schmidt, Australian National University This article is part of our series on big ideas for the Universities Accord. The federal government is calling for ideas to “reshape and reimagine higher education, and set it up for the next decade and beyond”. A review team is due to finish a draft report in June…
By Ian Lowe, Griffith University For decades, Australia has exported uranium – but not used it, other than in the Lucas Heights research reactor. But change is coming. We now face a rapidly deepening commitment to the nuclear industry, through nuclear submarines (bipartisan support) or nuclear reactors (Coalition support). The Albanese government was quick to accept…
By Kylie Walker, Australian National University This year’s federal budget is making up for decades of lost time – both in our clean energy transition and in betting on new technological breakthroughs. The Future Made in Australia Act holds tantalising potential for building Australian science, research and development. The aim is to turn Australia into…
A loss of sovereign control of industry is a key issue raised in our editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort – Here, Allen Roberts examines innovation in the critical food manufacturing sector. The recent declaration of ‘A Future Made in Australia’ by the Prime Minister Anthony Albanese has put the…
By Yasir Arafat, Edith Cowan University and Daryoush Habibi, Edith Cowan University As electric vehicle (EV) demand accelerates, so does the need for lithium batteries. But these batteries contain valuable critical minerals, as well as toxic materials, so they should not be treated as common waste. Unlike China and some European countries, Australia lacks a…
